(Q37097148)

18 August 2017

1 reference

title

Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice (English)

1 reference

18 August 2017

E Messadi-Laribi

1

1 reference

18 August 2017

V Griol-Charhbili

2

1 reference

18 August 2017

E Gaies

3

1 reference

18 August 2017

M P Vincent

4

1 reference

18 August 2017

D Heudes

5

1 reference

18 August 2017

P Meneton

6

1 reference

18 August 2017

F Alhenc-Gelas

7

1 reference

18 August 2017

C Richer

8

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Clinical and Experimental Pharmacology and Physiology

18 August 2017

published in

1 reference

18 August 2017

volume

35

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

489-493

1 reference

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Ligand triggers of classical preconditioning and postconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Kallikrein-kinin in stroke, cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Targeting kinin receptors for the treatment of tissue ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the brady

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2008.04902.X

10.1111/J.1440-1681.2008.04902.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference